HemaClear(R) to Launch Forearm Sterile Tourniquet Model at the 13th EFORT Congress

OHK Medical Devices, manufacturer of HemaClear®, the first and only sterile, single use surgical tourniquet that is cheaper and safer than the pneumatic tourniquet, will launch an innovative forearm sterile tourniquet, at the 13th EFORT Congress in Berlin on May 23rd-May 25th, 2012. This will be the first time HemaClear® is introduced to the German market.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Hemaclear

Haifa, Israel (PRWEB) May 22, 2012

OHK Medical Devices, manufacturer of HemaClear®, the first and only sterile, single use surgical tourniquet that is cheaper and safer than the pneumatic tourniquet, will launch an innovative forearm sterile tourniquet, at the 13th EFORT Congress in Berlin on May 23rd-May 25th, 2012. This will be the first time HemaClear® is introduced to the German market.

HemaClear® is the standard of care for bloodless orthopedic limb surgery It is a simple, sterile, safe and cost-effective device that exsanguinates, occludes and provides a clearer surgical field in a single, easy-to-use disposable product. The launch of the HemaClear® forearm model is part of the company's mission to provide an easier, cheaper, and safer orthopedic surgery solution.

"We are excited to offer our customers an economic solution for bloodless procedures done distal of the elbow," said Omer Inbar, International Sales & Marketing Manager, OHK Medical Devices. "We strongly believe that the HemaClear® forearm model can greatly benefit nurses and doctors by enhancing operating room efficacy, cutting costs, reducing the amount of tissue that is under ischemia, and contributing to successful surgical outcomes." Hemaclear® Forearm can be seen at booth F/07. The introduction of HemaClear® to the German marketplace, marks a significant milestone in the companies quest to make HemaClear® the standard of care.

About HemaClear®
HemaClear® is the original developer of sterile, disposable tourniquet technology that exsanguinates, occludes, and provides a clear surgical field. The technology not only reduces blood loss, infection, and the volume of ischemic tissue, its simplicity saves as much as fifteen minutes of critical OR set-up time‚ eliminating over 100 separate steps that can add as much as $300 to every procedure.

In fact, HemaClear is so revolutionary, it represents the single greatest advance in tourniquet technology since the Esmarch bandage. HemaClear® has been proven successful and medically safe worldwide in over 350,000 surgical cases, both in the OR and in the field, including disaster-struck areas across the world.

Founded in 1999, HemaClear® is based in Haifa, Israel, with offices in 30 countries covering over 2000 operating rooms. For more information about HemaClear®, visit http://www.hemaclear.com.


Contact